Phase
Alumni
Viraspec
Viraspec is bringing to market a novel rapid diagnostic test for COVID-19 that is faster, less expensive, easier to use, more reliable, more accurate, and able to triage risk groups and those needing immunisation. Given the current COVID-19 pandemic, Viraspec will be focusing on bringing to market a test to meet this immediate need. Viraspec will initially target professional applications (hospitals and clinics (permanent and in-field) and home care), with the ambition to eventually target at-home applications.
Robert Porter has 28 years experience in the medical diagnostic arena. He has led product development for CE, FDA and cFDA registration, and founded and grown three successful business.
Did you know?
Current rapid COVID-19 tests are too slow, not cost-effective, burdensome to use, have sensitivity and accuracy issues.
Excellence in solid material analysis
Amplify the efficacy of pharmaceutical treatments
Simplify medicine information through digital services
A "check-in buddy" for the elderly
Excellence in inhaler performance
Behavioral coaching app
Antibiotic-free treatment for vaginal bacterial infections
Digital tool for meeting an allergy doctor
Cutting-Edge Histological Solutions for Pharma Industry
Digital communication tool for titrating medicine
Mobile systems for movement analysis
Innovative solutions for better health care
GPS tracker system for elderly
Drug delivery platform
Healthtech for children with eating challenges
Digital health management tool
Short chain fatty acids can be delivered to the colon
Therapeutics after stroke
Starch pickering emulsion technology
Measuring thyroid hormone levels
Gene editing analysis solution
Cost-effective & rapid COVID-19 diagnostic test
eHealth clinic for obesity treatment
